Over a career spanning 43 years, the former CEO of Joslin Diabetes Center, John L. Brooks, has led international teams focused on healthcare private equity investment.
He was a founding General Partner of Prism Venture Partners, an early stage venture capital investment firm for nine years, and is a Director of the Pittsburgh Life Sciences Greenhouse, and its two accelerator funds.
Brooks currently serves as Chairman of the Board for a number of highly-regarded healthcare organizations including Cellnovo Group SA, the world’s first mobile diabetes management system; the College Diabetes Network, a diabetes-focused non-profit; and Thermalin Diabetes, LLC, a company focused on insulin technology. He is also a Board Member of Hygieia, Inc, a healthcare company specializing in insulin guidance systems, and Ammonett Pharma, a privately owned biotech company, amongst others.
45 years of experience in international healthcare projects, operations-facility planning, vocational teaching and quality assurance.
30 years of experience in hospital financial management and operations.
Nasser Massoud is a specialist in healthcare investments and public private partnerships with over 20 years of experience in the industry. He has extensive knowledge covering several markets including emerging Europe, MENA, Central Asia, the Caribbean and SEA. He spent several years as global head of transactions for a major international healthcare provider and has worked with governments, investors and international funding agencies on studying and structuring investments in a range of healthcare fields including digital health..
Nasser has a bachelors in engineering and a masters in economics and management, both from UCL; a masters in finance from London Business School; and is a Fellow of the Chartered Institute of Arbitrators. He is designated as a GHKOL (Global Healthcare Key Opinion Leader) by the Korean Health Industry Development Institute under the MoH of Korea, an appointment he has held since 2017. He is active in various global institutions such as the World Association of PPPs where he chairs the chapter on social sector PPPs (including healthcare); the United Nations Economic Commission for Europe where he participates on the team of experts for healthcare and digital health; and with the Harvard Business School Crossroads Athar initiative to accelerate the adoption of digital healthcare in the GCC countries.
Chairman of the EIT Health Supervisory Board, microbiologist, academic, founder of several biotech firms and board member of venture capital firms. Founding board member of EIT in 2008 and began his involvement in the EIT Health Supervisory Board in 2015.
Worked at the intersection of the healthcare industry, academia, and research throughout his career.
PhD, Genetics, University of Heidelberg.
Sophie Khau brings to the team 14 years of experience in private equity, corporate finance and entrepreneurship.
She started her career with AXA Private Equity, providing early stage and growth capital for SMEs in the technology and consumer sectors in Asia. She then joined the investment banking arm of BNP Paribas, advising large companies in Southeast Asia in mergers & acquisitions and equity capital markets transactions.
Subsequently, she expanded the footprint of the largest private sector group in Vietnam, Masan Group, through fundraising from private equity firms and other financial institutions and leading value accretive acquisitions for the group in Vietnam’s fast growing consumer space.
Sophie is passionate about investing and building businesses with transformative positive social impact particularly in the fields of healthcare and education. Currently, she oversees her family office’s investments in Asia within these sectors and leads strategic value-adding partnerships for organisations in these industries.
She holds a Master of Science in Management with an Entrepreneurship Major from HEC Paris Business School.
Lawrence Koh has 30 years of healthcare supply chain experience, working in various hospitals and clinics in Singapore, Bangkok, Yangon, Dhaka, Manila, Cairo, Shanghai and the United Arab Emirates.
Green field hospital projects such as Bumrungrad Hospital in Bangkok; Asian Hospital in Manila, Pun Hlaing hospital in Myanmar; Square Hospital in Dhaka, the new Al Mafraq Hospital in Abu Dhabi, Delta Health China Hospital in Shanghai and Cleveland Clinic in Abu Dhabi.
Brown-field hospital projects in Singapore such Singapore General Hospital, Mount Elizabeth Hospital, and East Shore Hospital; Al Rahba Hospital in Abu Dhabi and As Salam Hospital in Cairo. Lawrence also provided Supply Chain consultancy services to clients of GuidePoint Global (USA) and CognoLink (Hong Kong).
Lawrence received his Bachelor of Business degree with distinction in Transport and Logistics Management from the Royal Melbourne Institute of Technology, Australia. He is a citizen of Singapore and a Certified Materials & Resource Professional with the American Hospital Association USA.
30 years of experience in healthcare operations, field experiences and government financing.
Robert Mitchell joined TVM Capital Healthcare as an Advisor in December 2010 and serves as Chairman of the Amecath Board. In previous tenures, he served as President and Chief Executive Officer of Nellix, Inc., Executive Vice President and Chief Operating Officer of AngioDynamics, Inc., a publicly-traded medical device company, and as Chairman, President and Chief Executive Officer of Millimed Holdings, Inc., a privately-held medical device company based in Roskilde, Denmark.
Robert also served as Vice President of Worldwide Sales for Align Technology, Inc., a publicly-traded company, and held various positions with Cook Incorporated, a privately-held medical device company, including Vice President and Director, Global Sales and Marketing for various business units including diagnostic and interventional, endovascular, critical care.
Robert has several decades of experience, and a strong network and business understanding in the Asia Pacific region and has led several senior leadership teams resulting in corporate stability, profitability ahead of schedule, long term growth plans, and increased shareholder value
He holds a B.S. from the University of Utah and an MBA from Indiana Wesleyan University
Paola is a fund-of-funds investment specialist with a +25 year experience. After working in the investment funds department of Banque Privée Edomond de Rothschild (Luxembourg), Paola joined the European Investment Bank (EIB) in 1995. During her 24 year tenor with the EIB Group, her work mostly focused on fund of funds investments in Europe, the Middle East, India and Africa. Besides the investment activity she has conceived and developed new and innovative initiatives such as: (i) Boost Africa (a joint initiative between the European Investment Bank, the African for Development Bank and the European Commission focusing on supporting the nascent African Venture Capital industry through fund of funds investments and capacity building programmes for first time fund managers); (ii) the Space for Med Acceleration Programme (a knowledge transfer mechanism between the European Space Agency and MENA entrepreneurs); (iii) the MENA Seed Accelerators Facility (a capacity building programme for the newly created MENA accelerators in the wake of the Arab Spring).
Having retired from the European Investment Bank in September 2019, she is currently active advising fund managers worldwide. She is a coach with the International Climate Finance Accelerator, a public-private initiative promoted by the Luxembourg Government that supports emerging fund managers focusing on climate adaptation and mitigation related investments. She is a member of the Investment Committee of ANAVA, the Tunisian Fund of Funds. She is a senior advisor with Avanz Capital Egypt, an Egyptian asset management company. She is a coach in IFADA, a USAID funded programme to support the emergence of first time fund managers in Jordan and Iraq.
She holds a First Class Honours Degree in Classical Humanities from the Open University.